Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Erteberel in perimenopausal depression
NCT03689543Phase 2Completed
- Sponsor
- National Institute of Mental Health
- Start
- May 2019
- Primary completion
- Sep 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of erteberel in perimenopausal depression, sponsored by National Institute of Mental Health. Started May 2019; status: completed.
02
Drugs
erteberel
03
Conditions
perimenopausal depression
Beyond the preview
Go deeper on NCT03689543.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03689543.